SRJN: the cash flow

MyFinsight

For the quarter ending 2025-12-31, SRJN had -$1,300K decrease in cash & cash equivalents over the period. -$121,800K in free cash flow.

Cash Flow	2025-12-31
Net income	95,000
Depreciation and amortization	81,400
Deferred income taxes and investment tax credits	21,900
Accounts receivable	280,500
Inventories	-23,000
Regulatory assets and liabilities	-17,900
Accounts payable	92,000
Delayed/advance customer billings, net	-14,100
Taxes accrued	-45,300
Other assets and liabilities	-86,700
Other	3,000
Net cash provided by operating activities	81,000
Capital expenditures	202,800
Other	-1,500
Net cash used in investing activities	-201,300
Issuance of long-term debt, net	1,100,000
Repayment of long-term debt	7,500
(repayment) issuance of short-term debt	-905,000
Issuance of common stock	300
Dividends paid on common stock	47,200
Dividends paid on preferred stock	3,700
Debt issuance costs	12,700
Other	-5,200
Net cash provided by financing activities	119,000
Net (decrease) increase in cash, cash equivalents, and restricted cash	-1,300
Cash and cash equivalents at beginning of period	41,200
Cash and cash equivalents at end of period	39,900

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.